Author:
Feng Qin,Zhang Zheng,Shea Martin J,Creighton Chad J,Coarfa Cristian,Hilsenbeck Susan G,Lanz Rainer,He Bin,Wang Lei,Fu Xiaoyong,Nardone Agostina,Song Yongcheng,Bradner James,Mitsiades Nicholas,Mitsiades Constantine S,Osborne C Kent,Schiff Rachel,O'Malley Bert W
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology
Reference41 articles.
1. Clarke R, Liu MC, Bouker KB, et al. Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. Oncogene 2003; 22:7316–7339.
2. Ross-Innes CS, Stark R, Teschendorff AE, et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 2012; 481:389–393.
3. Lupien M, Meyer CA, Bailey ST, et al. Growth factor stimulation induces a distinct ER(alpha) cistrome underlying breast cancer endocrine resistance. Genes Dev 2010; 24:2219–2227.
4. Mayer I . Role of mTOR inhibition in preventing resistance and restoring sensitivity to hormone-targeted and HER2-targeted therapies in breast cancer. Clin Adv Hematol Oncol 2013; 11:217–224.
5. Munster PN, Thurn KT, Thomas S, et al. A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer. Br J Cancer 2011; 104:1828–1835.
Cited by
148 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献